CD200 and breast carcinoma: Besides some published potential biomarkers of breast cancer bone metastasis were identified in our study, we also detected some novel biomarkers or their relationship with breast cancer bone metastasis has never been reported, such as TNFAIP6, DHRS3, ASS1, RIPK4, VIM, CD200.